Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Prescription and alternative therapies for hair loss will be compared for effectiveness.

This study found that healthcare professionals, particularly dermatologists, can enhance their impact on social media by actively engaging across platforms and leveraging features like "Duet" or "Remix" to combat misinformation, highlighting their important role in optimizing public education on medical topics in a digital age.

This article presents an algorithmic approach to diagnosing, staging, and treating pattern hair loss and discusses hair transplant decision-making, without reporting new clinical results.

This study found that patients with alopecia areata had significantly higher troponin I levels compared to those with female pattern hair loss and healthy controls, suggesting an association with cardiovascular diseases.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

This study found that among Korean patients with pattern hair loss, the subjective severity of hair loss and socio-psychological stress influenced their expenditure and quality of life, rather than the clinical severity.

This article provides an overview of hair density, hair diameter, and the prevalence of female pattern hair loss but reports no new clinical findings.

This study found that a topical formulation containing DMG-Na significantly improved hair loss parameters in people experiencing hair loss, suggesting its potential effectiveness for such conditions.

This study reports that a dual cosmetic serum system by KilgourMD significantly improved hair loss in predominantly menopausal women over a 4-month period, as evidenced by objective and clinical assessments.

This study suggests that traditional classification systems for pattern hair loss, while useful in the past, have limitations in accuracy and reproducibility, and highlights the potential of integrating digital imaging and AI to create more precise and biologically informed classification frameworks.

This prospective observational study evaluated the use of Verilich serum for hair loss and found that 71.4% of chronic telogen effluvium patients saw significant improvement in hair shedding within 2 months, with no adverse events reported.

In this study, microneedling radiofrequency followed by topical exosome application was associated with significant increases in hair density and diameter, showing promising potential as a therapy for pattern hair loss.

In this study, researchers reported significant improvements in hair follicle diameter, thickness, and reduced hair root gap after treating male pattern hair loss with a regimen of Prachanna, Chitrakadi lepa, and Jeevamrutham lehyam over four months.

This article reports the first documented cases of Marie-Unna hereditary hypotrichosis in Egypt, highlighting the variability of genetic mutations in this rare form of congenital hair loss.

This study found distinct hair loss patterns among 112 women with female pattern hair loss, identifying unique presentations specifically in Asian, including South Asian, and Black women, which may influence treatment response across different racial groups.

This study found that three sessions of injectable platelet-rich fibrin (i-PRF+) significantly improved hair follicle density, hair volume, and thickness, as well as patient satisfaction in women with female pattern hair loss, with only minor self-limited adverse effects reported.

In this hospital-based case-control study, researchers at Bangabandhu Sheikh Mujib Medical University found that age, family history of alopecia, and low serum ferritin levels may be significant risk factors for female pattern hair loss among the studied population.

In this study, trichoscopy was found to be an effective noninvasive tool for diagnosing female pattern hair loss at early stages, potentially eliminating the need for scalp biopsies.

This study highlights the lack of sufficient Korean epidemiological research examining the psychosocial aspects of female pattern hair loss, the leading cause of hair loss among women.

This study found that there was no statistically significant difference in serum zinc levels between patients with pattern hair loss and healthy controls, and concluded that zinc deficiency is unlikely to be a direct cause of androgenetic alopecia.

This study found that 23.8% of participants with pattern hair loss had occipital involvement, with higher rates in females (35.6%) compared to males with early-stage hair loss (12.1%), illustrating significant gender differences in hair loss progression.

This study compared the effectiveness of topical finasteride, oral finasteride, and topical minoxidil over 12 months in postmenopausal women with androgenetic alopecia, exploring their therapeutic effects on this population. Results are not reported in the abstract.

This study found that a novel method of isolating human follicle stem cells from hair follicles via mechanical centrifugation, without culture conditions, promises to improve hair density in patients with Androgenetic Alopecia and some cases of Alopecia Areata.

In this study, injecting dermal sheath cup cells into affected areas of pattern hair loss improved hair thickness and patient-reported hair appearance in 62.9% of the participants, with better results in women, without serious side effects.

In this study, the researchers found that rare genetic variants make a minor contribution to male-pattern hair loss risk, identifying five significant gene associations, including novel genes, and noting a shared basis with monogenic hair loss disorders.

This study found that combining minoxidil and spironolactone was more effective for hair density and severity of hair loss in women with androgenic alopecia compared to minoxidil and finasteride, with no serious adverse effects reported.

This research highlights that while minoxidil and 5-alpha reductase inhibitors are commonly used for treating pattern hair loss, there is limited evidence supporting their relative effectiveness in women compared to men.

This review concluded that interleukin-17 is involved in the development of female-pattern baldness, suggesting a potential inflammatory role in the condition’s underlying causes.

This study observed a significant reduction in the number of hair follicles with a high proportion in catagen or telogen phase, along with visible vertical columns of connective tissue in the histopathologic examination.